Femto Technologies Inc., a pioneering FemTech company, has successfully completed a private placement financing round, securing approximately $17 million through an offering of common shares and warrants. The investment represents a significant milestone for the company's innovative feminine wellness technology.
The private placement involves the sale of common units at $4.17 per unit, which include common shares, Series A warrants, and Series B PIPE common warrants. Each warrant provides investors with additional potential equity at predetermined exercise prices of $5.21 and $12.51, respectively. The transaction is structured to provide flexibility and potential future value for institutional investors.
Sensera, the company's flagship product, stands at the forefront of this investment strategy. The feminine wellness device leverages proprietary Smart Release System (SRS) technology, incorporating machine learning and artificial intelligence to provide a personalized self-care experience. The CES Innovation Awards® 2025 Honorary recognition in the AI category underscores the device's technological sophistication.
The funding will be allocated toward general corporate purposes and working capital, enabling Femto Technologies to advance its research and development initiatives. This financial boost positions the company to potentially accelerate product development, expand market reach, and continue pioneering innovations in the FemTech sector.
The private placement highlights growing investor interest in technology-driven women's wellness solutions. By focusing on adaptive, intelligent devices that address comprehensive feminine health needs, Femto Technologies is establishing itself as a significant player in an emerging and promising market segment.
Aegis Capital Corp. served as the exclusive placement agent for this transaction, with legal counsel provided by Louis A. Brilleman, P.C. for the company and Kaufman & Canoles, P.C. for the placement agent.
While the company emphasizes that its current devices are in early development stages and subject to future testing and regulatory approvals, the substantial investment signals strong market confidence in Femto Technologies' technological approach and potential impact on feminine wellness innovation.
